Hereditary Protein C Deficiency Associated with Mutations in Exon IX of the Protein C Gene

Summary

This report describes five families with symptomatic hereditary protein C deficiency. Using a polymerase chain reaction (PCR)-based method, the entire coding sequence and intron-exon boundaries of the protein C gene was amplified from genomic DNA. In each family a single point mutation in the protein C gene was identified. Two unrelated families were found to share the same mutation, while the other three had different mutations. In the first two families with type I protein C deficiency the normal cytosine residue at nucleotide position 8551 in the protein C gene was replaced by thymidine leading to substitution of the normal proline residue at amino acid position 279 by leucine. In the third family with type I deficiency a previously undescribed mutation was identified. In this family the guanosine residue at position 8559 was replaced by adenosine (glycine 282 substituted by serine). In the fourth family, also with type I deficiency, guanosine 8589 was replaced by adenosine (glycine 292 substituted by serine). The fifth family had type II deficiency and in affected members cytosine 8769 was replaced by thymidine (arginine 352 substituted by tryptophan). All these mutations lead to amino acid substitutions in the serine protease domain of the mature protein. All were able to be confirmed by restriction enzyme analysis of PCR-derived DNA. In addition the novel mutation at nucleotide position 8559 was also demonstrable using single strand conformation polymorphism (SSCP) analysis of PCR-derived DNA. These mutations were likely examples of deamination of methylated cytosine occurring in cytosine-phosphate-guanosine (CpG) dinucleotide sequences. These findings confirm the genetic heterogeneity of hereditary protein C deficiency in these families.

• References

• 1 Esmon CT. The regulation of natural anticoagulant pathways. Science 1987; 235: 1348-1352
• 2 Clouse LH, Comp PC. The regulation of haemostasis: the protein C system. N Engl J Med 1988; 314: 1298-1304
• 3 Bovill EG, Bauer KA, Dickerman JD, Callas P, West B. The clinical spectrum of heterozygous protein C deficiency in a large New England kindred. Blood 1989; 73: 712-717
• 4 Miletich J, Sherman L, Broze G. Absence of thrombosis in subjects with heterozygous protein C deficiency. N E J Med 1987; 317: 991-996
• 5 Griffin J, Evatt B, Zimmerman T, Kleiss A, Wideman C. Deficiency of protein C in congenital thrombotic disease. J Clin Invest 1981; 68: 1370
• 6 Branson ME, Kutz J, Marble R, Griffin JM. Inherited protein C deficiency and coumadin-responsive relapsing pupura fulminans in a newborn infant. Lancet 1983; 2: 1165-1168
• 7 Marciniak E, Wilson MD, Morlar RA. Neonatal purpura fulminans: a genetic disorder related to the absence of protein C in blood. Blood 1985; 65: 15-20
• 8 Bertina RM, Broekmans AW, Krommenhoek-van EsC, Van Wijngaarden A. The use of a functional and immunological assay for plasma protein C in the study of the heterogeneity of congenital protein C deficiency. Thromb Haemost 1984; 51: 1-5
• 9 Foster DC, Davie EW. Characterization of a cDNA coding for human protein C. Proc Nat Acad Sci USA 1984; 81: 4766-4770
• 10 Foster DC, Yoshitake S, Davie EW. The nucleotide sequence of the gene for human protein C. Proc Nat Acad Sci USA 1985; 82: 4653-4677
• 11 Plutzky J, Hoskins J, Long G, Crabtree G. Evolution and organisation of the human protein C gene. Proc Nat Acad Sci USA 1986; 83: 546-550
• 12 Rocchi M, Roncuzzi L, Santamaria R, Archidiacono N, Dente L, Romeo G. Mapping through somatic cell hybrids and cDNA probes of protein C to chromosome 2, factor X to chromosome 13 and alpha-1-acid glycoprotein to chromosome 9. Hum Genet 1986; 74: 30-33
• 13 Reitsma PH, Poort SK, Bemardi F, Gandrilli S, Long GL, Sala N, Cooper DN. Protein C deficiency: A database of mutations. Thromb Haemost 1993; 69: 77-84
• 14 Bovill EG, Tomczak BGrant, Bhushan F, Pilemer E, Rainville IR, Long GC. Protein C Vermont: Symptomatic type 11 protein C deficiency associated with two Gla domain mutations. Blood 1992; 79: 1456-1465
• 15 Thompson AR. Molecular defects in haemophilia B. In: Impact of recombinant technology in Haemostasis and Thrombosis Hoyer LW, Drohan WN. eds. Plenum; New York: NY 1991. p 115
• 16 Davie LG, Dibner MD, Datley FJ. In: Basic methods in molecular biology Elsevier; New York: 1986. pp 44-46
• 17 Saiki RF, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, Mullis KB, Erlich A. Primer directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988; 239: 487-491
• 18 Sanger F, Nicklen S, Causon R. DNA sequencing with chain-terminating inhibitors. Proc Nat Acad Sci USA 1977; 74: 5463-5467
• 19 Orita M, Suzuki Y, Sekiya T, Hayashi K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 1989; 5: 874-879
• 20 Reitsma RH, Poort SK, Allaart CF, Briet RM. The spectrum of genetic defects in a panel of 40 Dutch families with symptomatic protein C deficiency type 1: Heterogeneity and founder effects. Blood 1991; 78: 890-894
• 21 Pfeffer SR, Rothman JE. Biosynthetic protein transport and sorting by the endoplasmic reticulum and Golgi. Ann Rev Biochem 1987; 56: 829-852
• 22 Lodish HF. Transport of secretary and membrane glycoproteins from the rough endoplasmic reticulum to the Golgi: A rate limiting step in protein maturation and secretion. J Biol Chem 1988; 263: 217
• 23 Kassenbrock CK, Garcia PD, Walter P, Kelly RB. Heavy-chain binding protein recognises aberrant poly-peptides translocated in vitro. Nature 1988; 333: 90
• 24 Rothman JE. Polypeptide chain binding proteins: catolytes of protein folding and related processes in cells. Cell 1989; 59: 591
• 25 Yamamoto K, Tanimoto M, Eni N, Matsushita T, Takamatsu J, Saito H. Impaired secretion of the elongated mutant of protein C (protein C-Nagoya). Molecular and cellular basis for hereditary protein C deficiency. J Clin Invest 1992; 90: 2439-2446
• 26 Wacey AI, Pemberton S, Cooper DN, Kakkar VV, Tuddenham EGD. A molecular model of the serine protease domain of activated protein C: application to the study of missense mutations causing protein C deficiency. Br J Haematol 1993; 84: 290-300
• 27 Cooper DN, Youssoufian M. The CpG dinucleotide and human genetic disease. Hum Genet 1988; 78: 151-155
• 28 Green PM, Bentley DR, Mibashan RS, Nilsson IM, Gianelli F. Molecular pathology of haemophilia B. EMBO 1989; 8: 1067-1072
• 29 Miletich JP. Laboratory diagnosis of protein C deficiency. Seminar Thromb Haemost 190 16: 179
• 30 Mannucci PM, Bayer C, Tripodi A, Givano-D’Angelo S, Wolf M, Valsecchi C, D’Angelo A, Meyer D, Larrieu MJ. Multicenter comparison of five functional and two immunological assays for protein C. Thromb Haemost 1987; 57: 44
• 31 Ott J. A short guide to linkage analysis. In: Human genetic diseases Davies KE. ed A practical approach IRL Press; Oxford: 1986
• 32 Forrest S, Catton RGH. Methods of detection of single base substitutions in clinical genetic practice. Mol Biol Med 1990; 7: 451-459